# FDA 483 - DermAvance Pharmaceuticals, Inc. - July 17, 2018

Source: https://www.keypedia.com/records/483/dermavance-pharmaceuticals-inc/4e0a3e44-fbff-411b-be4b-6fb93cbefc61

> FDA 483 for DermAvance Pharmaceuticals, Inc. on July 17, 2018. Product: other. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: DermAvance Pharmaceuticals, Inc.
- Inspection Date: 2018-07-17
- Product Type: other
- Office Name: Philadelphia District Office
- Summary: DermAvance Pharmaceuticals, Inc., a Commercial Sponsor-Monitor, was cited for a compliance issue during an FDA inspection. The firm failed to submit required annual progress reports for a significant risk device study. Specifically, the annual progress report for 2017 was not submitted to the FDA.

## Related Officers

- [Joseph L. Despins](https://www.keypedia.com/people/joseph-l-despins/c84402a8-7ebb-45ab-b1b9-c43a143c5fb8)

Company: https://www.keypedia.com/companies/dermavance-pharmaceuticals-inc/fd276aaf-86f4-43f8-b96d-6a5b9515ea7b

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8